DrugDashboards
← Home
Manufacturing facility

Delpharm Tours

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
France
Registered address
Rue Paul Langevin, Chambray-les-Tours, 37170, France (FRA)
Operations here
manufacture
FDA identifiers
FEI 3008349307 Β· DUNS 267589047

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2021-06-11
  • NAIDrug Quality Assurance2016-05-13
  • VAIDrug Quality Assurance2011-07-07

Drugs this plant is listed as making

0 distinct drugs across 0 products name this site in their FDA label.

No drug labels currently list this site.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Delpharm Tours β€” facility profile Β· DrugDashboards